Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Pérez-Beteta J, Molina-García D, Martínez-González A, Henares-Molina A, Amo-Salas M, Luque B, Arregui E, Calvo M, Borrás JM, Martino J, Velásquez C, Meléndez-Asensio B, de Lope ÁR, Moreno R, Barcia JA, Asenjo B, Benavides M, Herruzo I, Lara PC, Cabrera R, Albillo D, Navarro M, Pérez-Romasanta LA, Revert A, Arana E, Pérez-García VM. Pérez-Beteta J, et al. Among authors: herruzo i. Eur Radiol. 2019 Apr;29(4):1968-1977. doi: 10.1007/s00330-018-5758-7. Epub 2018 Oct 15. Eur Radiol. 2019. PMID: 30324390
Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival.
Molina D, Pérez-Beteta J, Luque B, Arregui E, Calvo M, Borrás JM, López C, Martino J, Velasquez C, Asenjo B, Benavides M, Herruzo I, Martínez-González A, Pérez-Romasanta L, Arana E, Pérez-García VM. Molina D, et al. Among authors: herruzo i. Br J Radiol. 2016 Aug;89(1064):20160242. doi: 10.1259/bjr.20160242. Epub 2016 Jun 20. Br J Radiol. 2016. PMID: 27319577 Free PMC article.
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
Pérez-Beteta J, Martínez-González A, Molina D, Amo-Salas M, Luque B, Arregui E, Calvo M, Borrás JM, López C, Claramonte M, Barcia JA, Iglesias L, Avecillas J, Albillo D, Navarro M, Villanueva JM, Paniagua JC, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Delgado MD, Del Valle A, Falkov A, Schucht P, Arana E, Pérez-Romasanta L, Pérez-García VM. Pérez-Beteta J, et al. Among authors: herruzo i. Eur Radiol. 2017 Mar;27(3):1096-1104. doi: 10.1007/s00330-016-4453-9. Epub 2016 Jun 21. Eur Radiol. 2017. PMID: 27329522 Free article.
Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.
Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA, Fernández-Romero A, Luque B, Arregui E, Calvo M, Borrás JM, Meléndez B, Rodríguez de Lope Á, Moreno de la Presa R, Iglesias Bayo L, Barcia JA, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Revert A, Arana E, Pérez-García VM. Pérez-Beteta J, et al. Among authors: herruzo i. Radiology. 2018 Jul;288(1):218-225. doi: 10.1148/radiol.2018171051. Radiology. 2018. PMID: 29924716 Free article.
Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Pérez-Beteta J, Molina-García D, Martínez-González A, Henares-Molina A, Amo-Salas M, Luque B, Arregui E, Calvo M, Borrás JM, Martino J, Velásquez C, Meléndez-Asensio B, de Lope ÁR, Moreno R, Barcia JA, Asenjo B, Benavides M, Herruzo I, Lara PC, Cabrera R, Albillo D, Navarro M, Pérez-Romasanta LA, Revert A, Arana E, Pérez-García VM. Pérez-Beteta J, et al. Among authors: herruzo i. Eur Radiol. 2019 May;29(5):2729. doi: 10.1007/s00330-018-5870-8. Eur Radiol. 2019. PMID: 30547198 Free article.
Should the prescription of oral anticancer drugs be restricted?
Ramos A, Torrecilla JL, Lara P, Herruzo I, Contreras J, Mañas A, Guedea F; board of directors of the Spanish Society of Radiation Oncology (SEOR). Ramos A, et al. Among authors: herruzo i. Rep Pract Oncol Radiother. 2012 Jul 19;17(4):187-9. doi: 10.1016/j.rpor.2012.07.003. eCollection 2012. Rep Pract Oncol Radiother. 2012. PMID: 24377022 Free PMC article. No abstract available.
Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer.
Cobo M, Delgado R, Gil S, Herruzo I, Baena V, Carabante F, Moreno P, Ruiz JL, Bretón JJ, Del Rosal JM, Fuentes C, Moreno P, García E, Villar E, Contreras J, Alés I, Benavides M. Cobo M, et al. Among authors: herruzo i. Clin Transl Oncol. 2006 Dec;8(12):903-11. doi: 10.1007/s12094-006-0154-1. Clin Transl Oncol. 2006. PMID: 17169764 Clinical Trial.
Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M, Guedea F, Suárez JF, de Paula B, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Boladeras A, Ayala A, Craven-Bratle J, Ávila M, Cunillera O, Pardo Y, Alonso J, Aguiló F; Clinically Localized Prostate Cancer. Ferrer M, et al. Among authors: herruzo i. Radiother Oncol. 2013 Aug;108(2):306-13. doi: 10.1016/j.radonc.2013.05.038. Epub 2013 Jul 9. Radiother Oncol. 2013. PMID: 23849168
Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study.
Suárez JF, Zamora V, Garin O, Gutiérrez C, Pont À, Pardo Y, Goñi A, Mariño A, Hervás A, Herruzo I, Cabrera P, Sancho G, Ponce de León J, Macías V, Guedea F, Vigués F, Castells M, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Suárez JF, et al. Among authors: herruzo i. Sci Rep. 2022 Jul 22;12(1):12589. doi: 10.1038/s41598-022-16395-w. Sci Rep. 2022. PMID: 35869124 Free PMC article.
Treatment of cancer with drugs: a controversy.
Guedea F, Macià M, Sanchez Calzado JA, Ramos A, Lopez Torrecilla JL, Herruzo I, Contreras J, Romero J, Willisch P; (Board of SEOR) on behalf of the Spanish Society for Radiation Oncology. Guedea F, et al. Among authors: herruzo i. Ann Oncol. 2011 Mar;22(3):747-748. doi: 10.1093/annonc/mdq760. Ann Oncol. 2011. PMID: 21343385 Free article. No abstract available.
52 results